-
Electronic (PDF)
-
Site License
-
Enterprisewide
Taiwan Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
Global Markets Direct, May 2009, Pages: 231
Taiwan Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
Summary
This report is an essential source for in-depth information and data relating to Taiwan cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices market in Taiwan.
Scope
- The report provides cardiovascular devices market information broken down into detailed categories and segments in Taiwan.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Reasons to buy
- Gain a strong understanding of the cardiovascular devices market in Taiwan.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in This Report
3.1 Cardiovascular Devices
3.2 Cardiac Rhythm Management
3.2.1 Cardiac Resynchronisation Therapy
3.2.1.1 Cardiac Resynchronisation Therapy - Defibrillator
3.2.1.2 Cardiac Resynchronisation Therapy - Pacemaker
3.2.2 Cardiovascular Pacing and ICD Leads
3.2.3 Implantable Cardioverter Defibrillator
3.2.3.1 Dual Chamber Implantable Cardioverter Defibrillator
3.2.3.2 Single Chamber Implantable Cardioverter Defibrillator
3.2.4 Pacemaker
3.2.4.1 Dual Chamber Pacemaker
3.2.4.2 Single Chamber Pacemaker
3.3 Cardiovascular Monitoring and Diagnostic Devices
3.3.1 ECG Monitoring Equipment
3.3.2 ECG Stress Testing Systems
3.3.3 Event Monitoring Systems
3.3.4 Holter Monitoring Systems
3.4 Cardiovascular Prosthetic Devices
3.4.1 Cardiac Assist Devices
3.4.1.1 Intra-Aortic Balloon Pump
3.4.1.2 Intra-Aortic Balloon Pump Catheters
3.4.1.3 Total Artificial Heart
3.4.1.4 Ventricular Assist Devices
3.4.2 Cardiac Valve Repair
3.4.3 Prosthetic Heart Valve
3.4.3.1 Mechanical Heart Valve
3.4.3.2 Tissue Heart Valve
3.5 Cardiovascular Surgery
3.5.1 Beating Heart Surgery Systems
3.5.2 Cardiac Ablation Devices
3.5.3 Cardiopulmonary Bypass Equipment
3.5.4 Perfusion Disposables
3.5.4.1 Custom Packs
3.5.4.2 Oxygenators
3.6 Electrophysiology
3.6.1 Electrophysiology Ablation Catheter
3.6.2 Electrophysiology Diagnostic Catheter
3.6.3 Electrophysiology Lab Systems
3.7 Interventional Cardiology
3.7.1 Arteriotomy Closure Devices
3.7.2 Cardiac Catheter
3.7.2.1 Angiography Catheter
3.7.2.2 Guiding Catheter
3.7.3 Coronary Guidewire
3.7.4 Coronary Stent
3.7.4.1 Bare Metal Stent
3.7.4.2 Drug Eluting Stent (DES)
3.7.5 PTCA Balloon
3.7.5.1 FW Balloon
3.7.5.2 Over the Wire Balloon
3.7.5.3 Rx Balloon
3.8 Peripheral Vascular Devices
3.8.1 Aortic Stent Graft
3.8.2 Embolic Protection Devices
3.8.3 Inferior Vena Cava Filter
3.8.4 Peripheral Guidewire
3.8.5 Peripheral Vascular Stent
3.8.6 PTA Balloon
3.8.7 Synthetic Surgical Grafts
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification
5.2 Pre-market Approval
5.3 Fast-track Approval
5.4 Registration Period
5.5 Labeling and Packaging
5.6 Post-market Surveillance
6 Pricing and Reimbursement
6.1 Reimbursement Application
6.2 Reimbursement Systems
7 Distribution Structure
8 Cardiovascular Devices in Taiwan
8.1 Cardiovascular Devices, Taiwan, Overall Revenue ($ mn), 2000-2015
8.2 Cardiovascular Devices, Taiwan, Category Volume (Units), 2000-2015
8.3 Cardiovascular Devices, Taiwan, Company Share (2007-2008)
9 Cardiac Rhythm Management In Taiwan
9.1 Cardiac Rhythm Management Overall Revenue (2000-2015)
9.1.1 Cardiac Resynchronisation Therapy Overall Revenue (2000-2015)
9.1.2 Implantable Cardioverter Defibrillator Overall Revenue (2000-2015)
9.1.3 Pacemaker Overall Revenue (2000-2015)
9.2 Cardiac Rhythm Management Overall Volume (2000-2015)
9.2.1 Cardiac Resynchronisation Therapy Overall Volume (2000-2015)
9.2.2 Implantable Cardioverter Defibrillator Overall Volume (2000-2015)
9.2.3 Pacemaker Overall Volume (2000-2015)
9.3 Cardiac Rhythm Management Average Price (2000-2015)
9.4 Cardiac Rhythm Management Distribution Share (2007-2008)
9.5 Cardiac Rhythm Management, Taiwan, Company Share (2007-2008)
10 Cardiovascular Monitoring and Diagnostic Devices In Taiwan
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015)
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015)
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008)
10.5 Cardiovascular Monitoring and Diagnostic Devices, Taiwan, Company Share (2007-2008)
11 Cardiovascular Prosthetic Devices In Taiwan
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015)
11.1.1 Cardiac Assist Devices Overall Revenue (2000-2015)
11.1.2 Prosthetic Heart Valve Overall Revenue (2000-2015)
11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2015)
11.2.1 Cardiac Assist Devices Overall Volume (2000-2015)
11.2.2 Prosthetic Heart Valve Overall Volume (2000-2015)
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015)
11.4 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
11.5 Cardiovascular Prosthetic Devices, Taiwan, Company Share (2007-2008)
12 Cardiovascular Surgery In Taiwan
12.1 Cardiovascular Surgery Overall Revenue (2000-2015)
12.1.1 Perfusion Disposables Overall Revenue (2000-2015)
12.2 Cardiovascular Surgery Overall Volume (2000-2015)
12.2.1 Perfusion Disposables Overall Volume (2000-2015)
12.3 Cardiovascular Surgery Average Price (2000-2015)
12.4 Cardiovascular Surgery Distribution Share (2007-2008)
12.5 Cardiovascular Surgery, Taiwan, Company Share (2007-2008)
13 Electrophysiology In Taiwan
13.1 Electrophysiology Overall Revenue (2000-2015)
13.2 Electrophysiology Overall Volume (2000-2015)
13.3 Electrophysiology Average Price (2000-2015)
13.4 Electrophysiology Distribution Share (2007-2008)
13.5 Electrophysiology, Taiwan, Company Share (2007-2008)
14 Interventional Cardiology In Taiwan
14.1 Interventional Cardiology Overall Revenue (2000-2015)
14.1.1 Cardiac Catheter Overall Revenue (2000-2015)
14.1.2 Coronary Stent Overall Revenue (2000-2015)
14.1.3 PTCA Balloon Overall Revenue (2000-2015)
14.2 Interventional Cardiology Overall Volume (2000-2015)
14.2.1 Cardiac Catheter Overall Volume (2000-2015)
14.2.2 Coronary Stent Overall Volume (2000-2015)
14.2.3 PTCA Balloon Overall Volume (2000-2015)
14.3 Interventional Cardiology Average Price (2000-2015)
14.4 Interventional Cardiology Distribution Share (2007-2008)
14.5 Interventional Cardiology, Taiwan, Company Share (2007-2008)
15 Peripheral Vascular Devices In Taiwan
15.1 Peripheral Vascular Devices Overall Revenue (2000-2015)
15.2 Peripheral Vascular Devices Overall Volume (2000-2015)
15.3 Peripheral Vascular Devices Average Price (2000-2015)
15.4 Peripheral Vascular Devices Distribution Share (2007-2008)
15.5 Peripheral Vascular Devices, Taiwan, Company Share (2007-2008)
16 Overview of Key Companies in Taiwan Cardiovascular Devices Market
16.1 Medtronic, Inc.
16.1.1 Company Overview
16.1.2 Value Chain Analysis
16.1.2.1 Manufacturing
16.1.2.2 Product Development
16.1.2.3 Sales and Marketing
16.1.3 Medtronic, Inc. Pipeline Products
16.1.3.1 Medtronic, Inc. Pipeline Products By Equipment Type
16.1.3.2 Medtronic, Inc. Pipeline Products By Development Stage
16.1.3.3 Medtronic, Inc. Pipeline Products By Therapy Area
16.1.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials
16.1.3.5 Medtronic, Inc. Pipeline Products By News Summary
16.2 Boston Scientific Corporation
16.2.1 Company Overview
16.2.2 Value Chain Analysis
16.2.2.1 Manufacturing
16.2.2.2 Product Development
16.2.2.3 Sales and Marketing
16.2.3 Boston Scientific Corporation Pipeline Products
16.2.3.1 Boston Scientific Corporation Pipeline Products By Equipment Type
16.2.3.2 Boston Scientific Corporation Pipeline Products By Development Stage
16.2.3.3 Boston Scientific Corporation Pipeline Products By Therapy Area
16.2.3.4 Boston Scientific Corporation Pipeline Products By Clinical Trials
16.2.3.5 Boston Scientific Corporation Pipeline Products By News Summary
16.3 St. Jude Medical, Inc.
16.3.1 Company Overview
16.3.2 Value Chain Analysis
16.3.2.1 Manufacturing
16.3.2.2 Product Development
16.3.2.3 Sales and Marketing
16.3.3 St. Jude Medical Inc. Pipeline Products
16.3.3.1 St. Jude Medical Inc. Pipeline Products By Equipment Type
16.3.3.2 St. Jude Medical Inc. Pipeline Products By Development Stage
16.3.3.3 St. Jude Medical Inc. Pipeline Products By Therapy Area
16.3.3.4 St. Jude Medical Inc. Pipeline Products By Clinical Trials
16.3.3.5 St. Jude Medical Inc. Pipeline Products By News Summary
16.4 Cordis Corporation
16.4.1 Company Overview
16.4.2 Cordis Corporation Pipeline Products
16.4.2.1 Cordis Corporation Pipeline Products By Equipment Type
16.4.2.2 Cordis Corporation Pipeline Products By Development Stage
16.4.2.3 Cordis Corporation Pipeline Products By Therapy Area
16.4.2.4 Cordis Corporation Pipeline Products By Clinical Trials
16.4.2.5 Cordis Corporation Pipeline Products By News Summary
16.5 Terumo Corporation
16.5.1 Company Overview
16.5.2 Value Chain Analysis
16.5.2.1 Manufacturing
16.5.2.2 Product Development
16.5.2.3 Sales and Marketing
16.5.3 Terumo Corporation Pipeline Products
16.5.3.1 Terumo Corporation Pipeline Products By Equipment Type
16.5.3.2 Terumo Corporation Pipeline Products By Development Stage
16.5.3.3 Terumo Corporation Pipeline Products By Therapy Area
16.5.3.4 Terumo Corporation Pipeline Products By Clinical Trials
16.5.3.5 Terumo Corporation Pipeline Products By News Summary
16.6 Abbott Laboratories
16.6.1 Company Overview
16.6.2 Value Chain Analysis
16.6.2.1 Manufacturing
16.6.2.2 Product Development
16.6.2.3 Sales and Marketing
16.7 Sorin S.p.A.
16.7.1 Company Overview
16.7.2 Value Chain Analysis
16.7.2.1 Manufacturing
16.7.2.2 Product Development
16.7.2.3 Sales and Marketing
16.7.3 Sorin Group Pipeline Products
16.7.3.1 Sorin Group Pipeline Products By Equipment Type
16.7.3.2 Sorin Group Pipeline Products By Development Stage
16.7.3.3 Sorin Group Pipeline Products By Therapy Area
16.7.3.4 Sorin Group Pipeline Products By Clinical Trials
16.7.3.5 Sorin Group Pipeline Products By News Summary
16.8 BIOTRONIK GmbH & Co. KG
16.8.1 Company Overview
16.8.2 BIOTRONIK GmbH & Co. KG Pipeline Products
16.8.2.1 BIOTRONIK GmbH & Co. KG Pipeline Products By Equipment Type
16.8.2.2 BIOTRONIK GmbH & Co. KG Pipeline Products By Development Stage
16.8.2.3 BIOTRONIK GmbH & Co. KG Pipeline Products By Therapy Area
16.8.2.4 BIOTRONIK GmbH & Co. KG Pipeline Products By Clinical Trials
16.8.2.5 BIOTRONIK GmbH & Co. KG Pipeline Products By News Summary
16.9 GE Healthcare
16.9.1 Company Overview
16.9.2 GE Healthcare Pipeline Products
16.9.2.1 GE Healthcare Pipeline Products By Equipment Type
16.9.2.2 GE Healthcare Pipeline Products By Development Stage
16.9.2.3 GE Healthcare Pipeline Products By Therapy Area
16.9.2.4 GE Healthcare Pipeline Products By Clinical Trials
16.9.2.5 GE Healthcare Pipeline Products By News Summary
16.10 Philips Healthcare
16.10.1 Company Overview
16.10.2 Value Chain Analysis
16.10.2.1 Manufacturing
16.10.2.2 Product Development
16.10.2.3 Sales and Marketing
16.11 Cardiac Science Corporation
16.11.1 Company Overview
16.11.2 Value Chain Analysis
16.11.2.1 Manufacturing
16.11.2.2 Product Development
16.11.2.3 Sales and Marketing
16.12 Nihon Kohden Corporation
16.12.1 Company Overview
16.12.2 Value Chain Analysis
16.12.2.1 Manufacturing
16.12.2.2 Product Development
16.12.2.3 Sales and Marketing
16.13 Edwards Lifesciences Corporation
16.13.1 Company Overview
16.13.2 Value Chain Analysis
16.13.2.1 Manufacturing
16.13.2.2 Product Development
16.13.2.3 Sales and Marketing
16.13.3 Edwards Lifesciences Corporation Pipeline Products
16.13.3.1 Edwards Lifesciences Corporation Pipeline Products By Equipment Type
16.13.3.2 Edwards Lifesciences Corporation Pipeline Products By Development Stage
16.13.3.3 Edwards Lifesciences Corporation Pipeline Products By Therapy Area
16.13.3.4 Edwards Lifesciences Corporation Pipeline Products By Clinical Trials
16.13.3.5 Edwards Lifesciences Corporation Pipeline Products By News Summary
16.14 MAQUET GmbH & Co. KG
16.14.1 Company Overview
16.15 Welch Allyn Inc.
16.15.1 Company Overview
16.16 OSI Systems, Inc.
16.16.1 Company Overview
16.16.2 Value Chain Analysis
16.16.2.1 Manufacturing
16.16.2.2 Product Development
16.16.2.3 Sales and Marketing
16.17 Datascope Corporation
16.17.1 Company Overview
16.17.2 Value Chain Analysis
16.17.2.1 Manufacturing
16.17.2.2 Product Development
16.17.2.3 Sales and Marketing
16.18 Arrow International, Inc.
16.18.1 Company Overview
16.18.2 Value Chain Analysis
16.18.2.1 Manufacturing
16.18.2.2 Product Development
16.18.2.3 Sales and Marketing
16.18.3 Arrow International, Inc. Pipeline Products
16.18.3.1 Arrow International, Inc. Pipeline Products By Equipment Type
16.18.3.2 Arrow International, Inc. Pipeline Products By Development Stage
16.18.3.3 Arrow International, Inc. Pipeline Products By Therapy Area
16.18.3.4 Arrow International, Inc. Pipeline Products By Clinical Trials
16.19 C.R. Bard, Inc.
16.19.1 Company Overview
16.19.2 Value Chain Analysis
16.19.2.1 Manufacturing
16.19.2.2 Product Development
16.19.2.3 Sales and Marketing
16.19.3 C.R. Bard, Inc. Pipeline Products
16.19.3.1 C.R. Bard, Inc. Pipeline Products By Equipment Type
16.19.3.2 C.R. Bard, Inc. Pipeline Products By Development Stage
16.19.3.3 C.R. Bard, Inc. Pipeline Products By Therapy Area
16.19.3.4 C.R. Bard, Inc. Pipeline Products By Clinical Trials
16.20 ev3 Inc.
16.20.1 Company Overview
16.20.2 Value Chain Analysis
16.20.2.1 Manufacturing
16.20.2.2 Product Development
16.20.2.3 Sales and Marketing
16.20.3 ev3 Inc. Pipeline Products
16.20.3.1 ev3 Inc. Pipeline ProductsBy Equipment Type
16.20.3.2 ev3 Inc. Pipeline Products By Development Stage
16.20.3.3 ev3 Inc. Pipeline Products By Therapy Area
16.20.3.4 ev3 Inc. Pipeline Products By Clinical Trials
16.20.3.5 ev3 Inc. Pipeline Products By News Summary
16.21 Biosense Webster, Inc.
16.21.1 Company Overview
16.22 BIOTEQUE CORPORATION
16.22.1 Company Overview
17 Appendix
17.1 Global Markets Direct Research Methodology
17.2 Coverage
17.3 Secondary Research
17.4 Primary Research
17.5 Models
17.6 Forecasts
17.7 Expert Panel Validation
17.8 Currency Conversion
17.9 Contact Us
17.10 Disclaimer
Executive Summary
1.1 List of Tables
Table 1: Public and private Hospitals in Taiwan, 2004 31
Table 2: Healthcare Personnel per 10,000 Population by Locality in Taiwan, 2005 31
Table 3: Specialty Beds in Hospitals by Accreditation in Taiwan, 2005 32
Table 4: Specialty Beds in Hospitals by Accreditation in Taiwan, 2005 32
Table 5: Medical Equipment Pre-market Approval in Taiwan, 2007 35
Table 6: Medical Equipment Evaluation Standards in Taiwan, 2007 39
Table 7: Cardiovascular Devices, Taiwan, Overall Revenue ($ mn), 2000-2015 44
Table 8: Cardiovascular Devices, Taiwan, Cross-Category Analysis, 2000-2015 45
Table 9: Cardiovascular Devices, Taiwan, Overall Revenue ($ mn), Historic, 2000-2008 47
Table 10: Cardiovascular Devices, Taiwan, Overall Revenue ($ mn), Forecast, 2008-2015 49
Table 11: Cardiovascular Devices, Taiwan, Category Volume (Units), 2000-2015 50
Table 12: Cardiovascular Devices, Taiwan, Category Volume (Units), Historic, 2000-2008 50
Table 13: Cardiovascular Devices, Taiwan, Category Volume (Units), Forecast, 2008-2015 51
Table 14: Cardiovascular Devices, Taiwan, Company Share by Revenue ($ mn), 2007-2008 52
Table 15: Cardiac Rhythm Management, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008 53
Table 16: Cardiac Rhythm Management, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015 54
Table 17: Cardiac Resynchronisation Therapy, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 55
Table 18: Cardiac Resynchronisation Therapy, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 56
Table 19: Implantable Cardioverter Defibrillator, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 57
Table 20: Implantable Cardioverter Defibrillator, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 58
Table 21: Pacemaker, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 59
Table 22: Pacemaker, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 60
Table 23: Cardiac Rhythm Management, Taiwan, Volume (Units) by Segment, Historic, 2000-2008 61
Table 24: Cardiac Rhythm Management, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015 62
Table 25: Cardiac Resynchronisation Therapy, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008 63
Table 26: Cardiac Resynchronisation Therapy, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015 64
Table 27: Implantable Cardioverter Defibrillator, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008 65
Table 28: Implantable Cardioverter Defibrillator, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015 66
Table 29: Pacemaker, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008 67
Table 30: Pacemaker, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015 68
Table 31: Cardiac Rhythm Management, Taiwan, Average Price ($), Historic, 2000-2008 69
Table 32: Cardiac Rhythm Management, Taiwan, Average Price ($), Forecast, 2008-2015 69
Table 33: Cardiac Rhythm Management, Taiwan, Distribution Share by Revenue ($mn), 2007-2008 70
Table 34: Cardiac Rhythm Management, Taiwan, Company Share by Revenue ($ mn), 2007-2008 71
Table 35: Cardiovascular Monitoring and Diagnostic Devices, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008 72
Table 36: Cardiovascular Monitoring and Diagnostic Devices, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015 73
Table 37: Cardiovascular Monitoring and Diagnostic Devices, Taiwan, Volume (Units) by Segment, Historic, 2000-2008 74
Table 38: Cardiovascular Monitoring and Diagnostic Devices, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015 75
Table 39: Cardiovascular Monitoring and Diagnostic Devices, Taiwan, Average Price ($), Historic, 2000-2008 76
Table 40: Cardiovascular Monitoring and Diagnostic Devices, Taiwan, Average Price ($), Forecast, 2008-2015 76
Table 41: Cardiovascular Monitoring and Diagnostic Devices, Taiwan, Distribution Share by Revenue ($mn), 2007-2008 77
Table 42: Cardiovascular Monitoring and Diagnostic Devices, Taiwan, Company Share by Revenue ($ mn), 2007-2008 78
Table 43: Cardiovascular Prosthetic Devices, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008 79
Table 44: Cardiovascular Prosthetic Devices, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015 80
Table 45: Cardiac Assist Devices, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 81
Table 46: Cardiac Assist Devices, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 82
Table 47: Prosthetic Heart Valve, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 83
Table 48: Prosthetic Heart Valve, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 84
Table 49: Cardiovascular Prosthetic Devices, Taiwan, Volume (Units) by Segment, Historic, 2000-2008 85
Table 50: Cardiovascular Prosthetic Devices, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015 86
Table 51: Cardiac Assist Devices, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008 87
Table 52: Cardiac Assist Devices, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015 88
Table 53: Prosthetic Heart Valve, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008 89
Table 54: Prosthetic Heart Valve, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015 90
Table 55: Cardiovascular Prosthetic Devices, Taiwan, Average Price ($), Historic, 2000-2008 91
Table 56: Cardiovascular Prosthetic Devices, Taiwan, Average Price ($), Forecast, 2008-2015 91
Table 57: Cardiovascular Prosthetic Devices, Taiwan, Distribution Share by Revenue ($mn), 2007-2008 92
Table 58: Cardiovascular Prosthetic Devices, Taiwan, Company Share by Revenue ($ mn), 2007-2008 93
Table 59: Cardiovascular Surgery, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008 94
Table 60: Cardiovascular Surgery, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015 95
Table 61: Perfusion Disposables, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 96
Table 62: Perfusion Disposables, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 97
Table 63: Cardiovascular Surgery, Taiwan, Volume (Units) by Segment, Historic, 2000-2008 98
Table 64: Cardiovascular Surgery, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015 98
Table 65: Perfusion Disposables, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008 99
Table 66: Perfusion Disposables, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015 100
Table 67: Cardiovascular Surgery, Taiwan, Average Price ($), Historic, 2000-2008 101
Table 68: Cardiovascular Surgery, Taiwan, Average Price ($), Forecast, 2008-2015 101
Table 69: Cardiovascular Surgery, Taiwan, Distribution Share by Revenue ($mn), 2007-2008 102
Table 70: Cardiovascular Surgery, Taiwan, Company Share by Revenue ($ mn), 2007-2008 103
Table 71: Electrophysiology, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008 104
Table 72: Electrophysiology, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015 105
Table 73: Electrophysiology, Taiwan, Volume (Units) by Segment, Historic, 2000-2008 106
Table 74: Electrophysiology, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015 106
Table 75: Electrophysiology, Taiwan, Average Price ($), Historic, 2000-2008 107
Table 76: Electrophysiology, Taiwan, Average Price ($), Forecast, 2008-2015 107
Table 77: Electrophysiology, Taiwan, Distribution Share by Revenue ($mn), 2007-2008 108
Table 78: Electrophysiology, Taiwan, Company Share by Revenue ($ mn), 2007-2008 109
Table 79: Interventional Cardiology, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008 111
Table 80: Interventional Cardiology, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015 113
Table 81: Cardiac Catheter, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 114
Table 82: Cardiac Catheter, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 115
Table 83: Coronary Stent, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 116
Table 84: Coronary Stent, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 117
Table 85: PTCA Balloon, Taiwan, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 118
Table 86: PTCA Balloon, Taiwan, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 119
Table 87: Interventional Cardiology, Taiwan, Volume (Units) by Segment, Historic, 2000-2008 120
Table 88: Interventional Cardiology, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015 121
Table 89: Cardiac Catheter, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008 122
Table 90: Cardiac Catheter, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015 123
Table 91: Coronary Stent, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008 124
Table 92: Coronary Stent, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015 125
Table 93: PTCA Balloon, Taiwan, Volume (Units) by Sub-Segment, Historic, 2000-2008 126
Table 94: PTCA Balloon, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2008-2015 127
Table 95: Interventional Cardiology, Taiwan, Average Price ($), Historic, 2000-2008 128
Table 96: Interventional Cardiology, Taiwan, Average Price ($), Forecast, 2008-2015 129
Table 97: Interventional Cardiology, Taiwan, Distribution Share by Revenue ($mn), 2007-2008 130
Table 98: Interventional Cardiology, Taiwan, Company Share by Revenue ($ mn), 2007-2008 131
Table 99: Peripheral Vascular Devices, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008 133
Table 100: Peripheral Vascular Devices, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015 135
Table 101: Peripheral Vascular Devices, Taiwan, Volume (Units) by Segment, Historic, 2000-2008 137
Table 102: Peripheral Vascular Devices, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015 139
Table 103: Peripheral Vascular Devices, Taiwan, Average Price ($), Historic, 2000-2008 140
Table 104: Peripheral Vascular Devices, Taiwan, Average Price ($), Forecast, 2008-2015 140
Table 105: Peripheral Vascular Devices, Taiwan, Distribution Share by Revenue ($mn), 2007-2008 141
Table 106: Peripheral Vascular Devices, Taiwan, Company Share by Revenue ($ mn), 2007-2008 142
Table 107: Medtronic, Inc. Pipeline Products by Equipment Type 146
Table 108: Medtronic, Inc. Pipeline Products By Development Stage 148
Table 109: Medtronic, Inc. Pipeline Products By Therapy Area 149
Table 110: Medtronic, Inc. Pipeline Products By Clinical Trials 151
Table 111: Medtronic, Inc. Pipeline Products By News Summary 152
Table 112: Boston Scientific Corporation Pipeline Products by Equipment Type 157
Table 113: Boston Scientific Corporation Pipeline Products By Development Stage 158
Table 114: Boston Scientific Corporation Pipeline Products By Therapy Area 159
Table 115: Boston Scientific Corporation Pipeline Products By Clinical Trials 160
Table 116: Boston Scientific Corporation Pipeline Products By News Summary 161
Table 117: St. Jude Medical Inc. Pipeline Products by Equipment Type 165
Table 118: St. Jude Medical Inc. Pipeline Products By Development Stage 166
Table 119: St. Jude Medical Inc. Pipeline Products By Therapy Area 167
Table 120: St. Jude Medical Inc. Pipeline Products By Clinical Trials 168
Table 121: St. Jude Medical Inc. Pipeline Products By News Summary 168
Table 122: Cordis Corporation Pipeline Products by Equipment Type 169
Table 123: Cordis Corporation Pipeline Products By Development Stage 169
Table 124: Cordis Corporation Pipeline Products By Therapy Area 170
Table 125: Cordis Corporation Pipeline Products By Clinical Trials 170
Table 126: Cordis Corporation Pipeline Products By News Summary 170
Table 127: Terumo Corporation Pipeline Products by Equipment Type 173
Table 128: Terumo Corporation Pipeline Products By Development Stage 173
Table 129: Terumo Corporation Pipeline Products By Therapy Area 174
Table 130: Terumo Corporation Pipeline Products By Clinical Trials 174
Table 131: Terumo Corporation Pipeline Products By News Summary 174
Table 132: Sorin Group Pipeline Products by Equipment Type 182
Table 133: Sorin Group Pipeline Products By Development Stage 182
Table 134: Sorin Group Pipeline Products By Therapy Area 183
Table 135: Sorin Group Pipeline Products By Clinical Trials 183
Table 136: Sorin Group Pipeline Products By News Summary 183
Table 137: BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type 184
Table 138: BIOTRONIK GmbH & Co. KG Pipeline Products By Development Stage 184
Table 139: BIOTRONIK GmbH & Co. KG Pipeline Products By Therapy Area 185
Table 140: BIOTRONIK GmbH & Co. KG Pipeline Products By Clinical Trials 185
Table 141: BIOTRONIK GmbH & Co. KG Pipeline Products By News Summary 185
Table 142: GE Healthcare Pipeline Products by Equipment Type 186
Table 143: GE Healthcare Pipeline Products By Development Stage 186
Table 144: GE Healthcare Pipeline Products By Therapy Area 187
Table 145: GE Healthcare Pipeline Products By Clinical Trials 187
Table 146: GE Healthcare Pipeline Products By News Summary 187
Table 147: Edwards Lifesciences Corporation Pipeline Products by Equipment Type 200
Table 148: Edwards Lifesciences Corporation Pipeline Products By Development Stage 201
Table 149: Edwards Lifesciences Corporation Pipeline Products By Therapy Area 201
Table 150: Edwards Lifesciences Corporation Pipeline Products By Clinical Trials 202
Table 151: Edwards Lifesciences Corporation Pipeline Products By News Summary 202
Table 152: Arrow International, Inc. Pipeline Products by Equipment Type 213
Table 153: Arrow International, Inc. Pipeline Products By Development Stage 213
Table 154: Arrow International, Inc. Pipeline Products By Therapy Area 214
Table 155: Arrow International, Inc. Pipeline Products By Clinical Trials 214
Table 156: C.R. Bard, Inc. Pipeline Products by Equipment Type 217
Table 157: C.R. Bard, Inc. Pipeline Products By Development Stage 218
Table 158: C.R. Bard, Inc. Pipeline Products By Therapy Area 218
Table 159: C.R. Bard, Inc. Pipeline Products By Clinical Trials 219
Table 160: ev3 Inc. Pipeline Products by Equipment Type 222
Table 161: ev3 Inc. Pipeline Products By Development Stage 222
Table 162: ev3 Inc. Pipeline Products By Therapy Area 223
Table 163: ev3 Inc. Pipeline Products By Clinical Trials 223
Table 164: ev3 Inc. Pipeline Products By News Summary 223
Table 165: USD to Local Currency, Average Exchange Rate 2008 229
Medtronic, Inc.
Boston Scientific Corporation
St. Jude Medical, Inc.
Cordis Corporation
Terumo Corporation
Abbott Laboratories
Sorin S.p.A.
BIOTRONIK GmbH & Co. KG
GE Healthcare
Philips Healthcare
Cardiac Science Corporation
Nihon Kohden Corporation
Edwards Lifesciences Corporation
MAQUET GmbH & Co. KG
Welch Allyn Inc.
OSI Systems, Inc.
Datascope Corporation
Arrow International, Inc.
C.R. Bard, Inc.
ev3 Inc.
Biosense Webster, Inc.
BIOTEQUE CORPORATION
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
